Âé¶¹´«Ã½ÍøÕ¾

Diamond Therapeutics Signs Agreement with Âé¶¹´«Ã½ÍøÕ¾ for Research on Low-Dose LSD

Published: 4 February 2021

TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...

Active Startup: Laurent Pharma

Published: 10 October 2019

Business Snapshot...

Open Lab- Stem Cells and Neural Organoids

Published: 5 February 2020

The Early Drug Discovery Unit (EDDU) at the Montreal Neurological Institute (The Neuro) works to accelerate drug discovery, with the ultimate goal of improving the lives of people living with...

Reminder: Canada Research Continuity Emergency Fund (CRCEF)

Published: 10 November 2020

This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.

Pages

Back to top